Commentary
Fed. Circ. OKs Boston Drug Developer's Patent Win Fed. Circ. OKs Boston Drug Developer's Patent Win
March 11, 2024
Law360Commentary
Law360’s Legal Lions of the Week Law360’s Legal Lions of the Week
February 23, 2024
Law360 PulseCommentary
These Firms Are Leading in PTAB Work These Firms Are Leading in PTAB Work
February 8, 2024
Press Release
Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked
June 30, 2023
Intellectual Asset ManagementCommentary
These Firms Are Pulling In The Most PTAB Work These Firms Are Pulling In The Most PTAB Work
February 17, 2023
Law360Commentary
The IP News That Mattered Most in 2022, According to You The IP News That Mattered Most in 2022, According to You
December 19, 2022
IPWatchdogCommentary
USPTO Director Kathi Vidal Is Wielding Review Authority to Change Policy on Discretionary Denials USPTO Director Kathi Vidal Is Wielding Review Authority to Change Policy on Discretionary Denials
September 23, 2022
Intellectual Asset ManagementPress Release
45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked 45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked
July 8, 2022
Intellectual Asset ManagementCommentary
Fintiv Guidance Vexes Doctrine’s In-House Backers and Critics Fintiv Guidance Vexes Doctrine’s In-House Backers and Critics
June 22, 2022
Managing Intellectual PropertyCommentary
Vidal Memo Clarifying PTAB Discretionary Denial Analysis Says Fintiv Does Not Apply to Parallel ITC Investigations Vidal Memo Clarifying PTAB Discretionary Denial Analysis Says Fintiv Does Not Apply to Parallel ITC Investigations
June 22, 2022
IPWatchdogCommentary
Vidal's New Guidance May Make Fintiv Denials Even Rarer Vidal's New Guidance May Make Fintiv Denials Even Rarer
June 22, 2022
Law360Commentary
'Fintiv' Patent Review Denials Fall as Calls to End Rule Persist 'Fintiv' Patent Review Denials Fall as Calls to End Rule Persist
May 31, 2022
Bloomberg LawDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.